EIR Ventures
  • This is Eir Ventures
  • Team
  • Investments
  • Sustainability
  • News
  • Contact
    • Investor Login
    • Download
Select Page
Interview with Eir Ventures’ Magnus Persson in Dagens Industri

Interview with Eir Ventures’ Magnus Persson in Dagens Industri

by Thomas Rønn | Jan 25, 2021 | Other News

För 25 år sedan var han med och grundade Healthcap. Nu har Magnus Persson gjort det igen, med Eir Ventures, har han startat ett nytt bolag specialiserat på life science-investeringar. ”Sverige och Norden har länge visat sig fantastiskt när det gäller innovation”,...
New Nordic Life Science Venture Fund, Eir Ventures, launched to leverage the untapped potential of Health Care Innovation

New Nordic Life Science Venture Fund, Eir Ventures, launched to leverage the untapped potential of Health Care Innovation

by Thomas Rønn | Jan 23, 2021 | Articles, Other News

Life sciences focused fund also announces first close of EUR76 million July 10, 2020, Stockholm & Copenhagen: Eir Ventures, a Nordic Life Science Venture Fund, today announced a first close of its new fund of EUR76 million. With a strong base in the Nordic region...

Recent Posts

  • Eir Ventures invests in Henlez
  • Eir Ventures portfolio company, Pretzel Therapeutics, announces USD 72,5M series A financing
  • Eir Ventures invests in Hoba Therapeutics
  • Eir Ventures joins oversubscribed investment round in Attgeno
  • Eir Ventures strengthens team – appoints three new Partners

Recent Comments

    Get in Touch
    Eir Ventures is located in Stockholm, Sweden, and Copenhagen, Denmark.
    Sweden Office
    Grev Turegatan 27
    SE-114 38 Stockholm
    Sweden
    Denmark Office
    Havnegade 39
    DK-1058 Copenhagen
    Denmark
    Contact us
    info@eirventures.eu
    ©2021 Eir Ventures.